Philip Ma

CEO at PrognomiQ

Philip Ma is Chief Executive Officer, Founder, and Board member for PrognomiQ. Previously, he was Chief Business Officer, President, and Founder of Seer. Prior to this, he was Vice-President for Digital Health Technologies and Data Sciences at Biogen, a group that he established to discover insights and create value for Biogen and its patients. Before joining Biogen, Philip was Senior Partner at McKinsey & Company, where he served global leaders in the pharmaceutical and biotech sectors, leading the West Coast Healthcare Practice and global Personalized Medicine practice for the Firm. Philip was a macromolecular crystallographer in the lab of Dr. Carl O. Pabo at the Massachusetts Institute of Technology, where he received his Ph.D. in Biology. Philip also has degrees in Biochemistry (A.B. from Harvard College) and in Economics (MPhil from Oxford University, where he was a Rhodes Scholar).

Location

San Mateo, United States

Links

Previous companies


Org chart


Teams


Offices


PrognomiQ

1 followers

PrognomiQ aims to generate proteomic information with high accuracy, scale and speed. This proteomic data will be complemented with genomic, metabolomic and other health information to deliver first-in-class test products that enable early disease detection and treatment.


Industries

Employees

11-50

Links